Two Sigma Investments’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.13M | Sell |
115,828
-9,396
| -8% | -$108K | ﹤0.01% | 2710 |
|
|
2025
Q4 | $1.49M | Buy |
125,224
+96,906
| +342% | +$1.23M | ﹤0.01% | 2670 |
|
|
2025
Q3 | $337K | Buy |
+28,318
| New | +$376K | ﹤0.01% | 3169 |
|
|
2024
Q4 | – | Sell |
-446
| Closed | -$7.54K | – | 3311 |
|
|
2024
Q3 | $7.54K | Buy |
+446
| New | +$9.36K | ﹤0.01% | 3055 |
|
|
2024
Q1 | – | Sell |
-596
| Closed | -$141K | – | 3153 |
|
|
2023
Q4 | $141K | Sell |
596
-545
| -48% | -$84.7K | ﹤0.01% | 2902 |
|
|
2023
Q3 | $171K | Sell |
1,141
-756
| -40% | -$119K | ﹤0.01% | 2669 |
|
|
2023
Q2 | $330K | Sell |
1,897
-1,809
| -49% | -$303K | ﹤0.01% | 2488 |
|
|
2023
Q1 | $467K | Buy |
3,706
+1,522
| +70% | +$343K | ﹤0.01% | 2231 |
|
|
2022
Q4 | $662K | Sell |
2,184
-99
| -4% | -$14.6K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $126K | Sell |
2,283
-940
| -29% | -$67.6K | ﹤0.01% | 2195 |
|
|
2022
Q2 | $193K | Sell |
3,223
-985
| -23% | -$72.9K | ﹤0.01% | 2174 |
|
|
2022
Q1 | $480K | Sell |
4,208
-1,895
| -31% | -$222K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $879K | Buy |
6,103
+1,118
| +22% | +$203K | ﹤0.01% | 2676 |
|
|
2021
Q3 | $1.09M | Buy |
4,985
+2,729
| +121% | +$578K | ﹤0.01% | 2539 |
|
|
2021
Q2 | $523K | Sell |
2,256
-6,407
| -74% | -$1.63M | ﹤0.01% | 3055 |
|
|
2021
Q1 | $2.61M | Buy |
8,663
+910
| +12% | +$326K | 0.01% | 1499 |
|
|
2020
Q4 | $2.92M | Buy |
7,753
+4,687
| +153% | +$1.64M | 0.01% | 1256 |
|
|
2020
Q3 | $941K | Sell |
3,066
-1,664
| -35% | -$636K | ﹤0.01% | 1799 |
|
|
2020
Q2 | $1.78M | Buy |
4,730
+1,973
| +72% | +$559K | 0.01% | 1160 |
|
|
2020
Q1 | $629K | Buy |
2,757
+749
| +37% | +$286K | 0.01% | 1768 |
|
|
2019
Q4 | $1.06M | Buy |
2,008
+768
| +62% | +$416K | ﹤0.01% | 2125 |
|
|
2019
Q3 | $534K | Buy |
+1,240
| New | +$797K | ﹤0.01% | 2507 |
|
|
2019
Q1 | – | Sell |
-161
| Closed | -$152K | – | 3231 |
|
|
2018
Q4 | $152K | Buy |
+161
| New | +$194K | ﹤0.01% | 2765 |
|
|
2018
Q1 | – | Sell |
-229
| Closed | -$384K | – | 3322 |
|
|
2017
Q4 | $384K | Buy |
+229
| New | +$303K | ﹤0.01% | 2598 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM